- Report
- May 2023
- 220 Pages
Global
From €3379EUR$3,500USD£2,861GBP
- Report
- November 2021
- 73 Pages
Global
From €4779EUR$4,950USD£4,047GBP
- Report
- June 2021
- 77 Pages
Global
From €4779EUR$4,950USD£4,047GBP
- Report
- August 2020
- 109 Pages
Global
From €4103EUR$4,250USD£3,475GBP
- Report
- November 2022
- 220 Pages
Global
From €3331EUR$3,450USD£2,821GBP
- Report
- April 2023
- 115 Pages
Global
From €4586EUR$4,750USD£3,883GBP
- Report
- August 2022
- 120 Pages
Global
From €4586EUR$4,750USD£3,883GBP
- Report
- June 2020
- 71 Pages
Europe
From €4586EUR$4,750USD£3,883GBP
From €2028EUR$2,100USD£1,717GBP
€2897EUR$3,000USD£2,453GBP
- Report
- May 2021
Asia Pacific
From €2028EUR$2,100USD£1,717GBP
€2897EUR$3,000USD£2,453GBP
- Report
- May 2021
Middle East, Africa
From €2028EUR$2,100USD£1,717GBP
€2897EUR$3,000USD£2,453GBP
From €2028EUR$2,100USD£1,717GBP
€2897EUR$3,000USD£2,453GBP
- Report
- April 2021
North America
From €2028EUR$2,100USD£1,717GBP
€2897EUR$3,000USD£2,453GBP
- Report
- December 2020
- 114 Pages
From €2028EUR$2,100USD£1,717GBP
€2897EUR$3,000USD£2,453GBP
- Report
- December 2020
- 117 Pages
Middle East, Africa
From €2028EUR$2,100USD£1,717GBP
€2897EUR$3,000USD£2,453GBP
- Report
- February 2021
Global
From €3075EUR$3,185USD£2,604GBP
€4393EUR$4,550USD£3,720GBP
- Report
- October 2020
- 136 Pages
Europe
From €2028EUR$2,100USD£1,717GBP
€2897EUR$3,000USD£2,453GBP
- Report
- October 2020
- 133 Pages
Asia Pacific
From €2028EUR$2,100USD£1,717GBP
€2897EUR$3,000USD£2,453GBP
- Report
- October 2020
- 123 Pages
North America
From €2028EUR$2,100USD£1,717GBP
€2897EUR$3,000USD£2,453GBP
- Report
- August 2020
- 183 Pages
Global
From €3075EUR$3,185USD£2,604GBP
€4393EUR$4,550USD£3,720GBP
![Loading Indicator](//www.researchandmarkets.com/images/loading.gif)
The MicroRNA market is a subset of the genomics industry that focuses on the study of small, non-coding RNA molecules. MicroRNAs are involved in a variety of biological processes, including gene expression, development, and disease. They are increasingly being studied as potential therapeutic targets for a variety of diseases, including cancer, cardiovascular disease, and neurological disorders.
The market for microRNA-based therapeutics is growing rapidly, driven by advances in sequencing technology and the development of new delivery systems. Companies are developing a variety of products, including diagnostics, therapeutics, and research tools.
Some of the major players in the microRNA market include Thermo Fisher Scientific, Illumina, Qiagen, Merck, and Novartis. Other companies, such as Exiqon, Bio-Rad, and Bio-Techne, are also active in the market. Show Less Read more